Pathophysiology of migraine chronification

Neurological Sciences

Volumn 31, Issue SUPPL.1, 2010, Pages

  Aguggia, M ^a   Saracco, M G ^a  

^a CARDINAL MASSAIA HOSPITAL   (Italy)

Author keywords

Chronic migraine; Migraine progression; Transformation

Indexed keywords

ANALGESIC AGENT; CAFFEINE; ERGOTAMINE DERIVATIVE; NARCOTIC ANALGESIC AGENT; TRIPTAN DERIVATIVE;

ALLODYNIA; ARTICLE; CHRONIC DAILY HEADACHE; CHRONICITY; DEPRESSION; DRUG ABUSE; HUMAN; LIFE EVENT; MIGRAINE; NEUROMODULATION; NOCICEPTION; OBESITY; PATHOPHYSIOLOGY; PERIAQUEDUCTAL GRAY MATTER; SNORING; TRANSFORMED MIGRAINE; TRIGEMINAL NUCLEUS; CHRONIC DISEASE; DISEASE COURSE; REVIEW; RISK FACTOR;

CHRONIC DISEASE; DISEASE PROGRESSION; HUMANS; MIGRAINE DISORDERS; RISK FACTORS;

EID: 77955861797     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-010-0264-y     Document Type: Article

References (33)

1. Stewart WF, Shechter A, Lipton RB (1994) Migraine heterogeneity, disability, pain intensity, and attack frequency and duration. Neurology 44(Suppl 4):S24-S39
2. Bigal ME, Lipton RB (2008) Clinical course in migraine. Neurology 71:848-855
3. Scher AI, Migdette LA, Lipton RB (2008) Risk factors for headache chronification. Headache 48:16-25
4. Lipton RB (2009) Tracing transformation: chronic migraine classification, progression and epidemiology. Neurology 72(5 Suppl 1):S3-S7
5. Welch KMA, Barkley GL, Tepley N et al (1993) Central neurogenic mechanisms of migraine. Neurology 43:S21-S25
6. Goadsby PJ, Lipton RB, Ferrari MD (2002) Migraine-current understanding and treatment. N Engl J Med 346:257-270
7. Silberstein SD, Lipton RB, Sliwinski M (1996) Classification of daily and near-daily headache: A field study of revised HIS criteria. Neurology 47:871-875
8. (2004) Headache Classification Committee of the International Classification of Headache Disorders, 2nd edn. Cephalalgia Suppl 1):1-160
9. Zwart JA, Dyb G, Hagen K, Swebak S, Holmen J (2003) Analgesic use: A predictor of chronic pain and medication overuse headache. Neurology 61:160-164 (Pubitemid 36875294)
10. Limmroth V, Katsarava Z, Fritsche G et al (2002) Features of medication overuse headache following overuse of different acute headache drugs. Neurology 59:1011-1014
11. Saper J (2002) Borderline personality disorder and the chronic headache patient: review and management recommendations. Headache 42:663-673
12. Mao J (2002) Opioid-induce abnormal pain sensitivity: implications in clinical practice. Pain 100:213-217 (Pubitemid 35449233)
13. Meng ID, Porreca F (2004) Basic science: mechanisms of medication overuse. Headache Curr 1:47-54
14. Lipton RB, Bigal ME (2008) Looking to the future: research designs for study of headache disease progression. Headache 48:58-66
15. Granziera C, DaSilva AF, Snyder J, Tuch DS, Hadjikhani N (2006) Anatomical alterations of the visual motion processing network in migraine with and without aura. PLoS Med 3:e402
16. Ambrosini A, Rossi P, De Pasqua V, Pierelli F, Schoenen J (2003) Lack of habituation causes high intensity dependence of auditory evoked cortical potentials in migraine. Brain 126:2009-2015 (Pubitemid 37059440)
17. Lipton RB, Hamelsky SW, Kolodner KB, Steiner TJ, Stewart WF (2000) Migraine, quality of life, and depression: A populationbased case-control study. Neurology 55:629-635
18. Haut SR, Bigal ME, Lipton RB (2006) Chronic disorders with episodic manifestations: focus on epilepsy and migraine. Lancet Neurol 5:148-157 (Pubitemid 43107850)
19. Silberstein SD, Lipton RB, Sliwinski M (1996) Classification of daily and near-daily headaches: field trial of revised IHS criteria. Neurology 47:871-875
20. Mathew NT, Reuveni U, Perez F (1987) Transformed or evolutive migraine. Headache 27:102-106 (Pubitemid 17152607)
21. Welch KM, Goadsby PJ (2002) Chronic daily headache: nosology and pathophysiology. Curr Opin Neurol 15:287-295 (Pubitemid 34596892)
22. Scher AI, Stewart WF, Ricci JA, Lipton RB (2003) Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 106:81-89 (Pubitemid 37329617)
23. Lipton RB, Bigal ME, Diamond M et al (2007) Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68:343-349 (Pubitemid 46184209)
24. Boardman HF, Thomas E, Millson DS, Croft PR (2006) The natural history of headache: predictors of onset and recovery. Cephalalgia 26:1080-1088 (Pubitemid 44199399)
25. Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH (2000) An association between migraine and cutaneous allodynia. Ann Neurol 47:614-624 (Pubitemid 30261897)
26. Kruit MC, van Buchem MA, Hofman PA et al (2004) Migraine as a risk factor for subclinical brain lesions. JAMA 291:427-434 (Pubitemid 38129746)
27. Ashkenazi A, Silberstein S, Jakubowski M, Burstein R (2007) Improved identification of allodynic migraine patients using a questionnaire. Cephalalgia 27:325-329 (Pubitemid 46434961)
28. Burstein R, Cutrer MF, Yarnitsky D (2000) The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 123:1703-1709 (Pubitemid 30481193)
29. Knight YE, Goadsby PJ (2001) The periaqueductal gray matter modulates trigeminovascular input: A role in migraine? Neuroscience 106:793-800 (Pubitemid 33000183)
30. Hoskin KL, Bulmer DCE, Lasalandra M, Jonkman A, Goadsby PJ (2001) Fos expression in the midbrain periaqueductal grey after trigeminovascular stimulation. J Anat 197:29-35 (Pubitemid 32164426)
31. Welch KMA, Nagesh V, Aurora SK, Gelman N (2001) Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 41:629-637 (Pubitemid 32777745)
32. Rozen TD (2007) Vanishing cerebellar infarcts in a migraine patient. Cephalalgia 27:557-560 (Pubitemid 46848915)
33. Moskowitz MA, Kurth T (2007) Blood vessels, migraine, and stroke. Stroke 63:148-158